Penco Arturo, Bossini Benedetta, Giangreco Manuela, Vidonis Viviana, Vittori Giada, Grassi Nicoletta, Pellegrin Maria Chiara, Faleschini Elena, Barbi Egidio, Tornese Gianluca
University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
Front Endocrinol (Lausanne). 2021 Mar 22;12:660692. doi: 10.3389/fendo.2021.660692. eCollection 2021.
Pediatric endocrinology rely greatly on hormone stimulation tests which demand time, money and effort. The knowledge of the pattern of pediatric endocrinology stimulation tests is therefore crucial to optimize resources and guide public health interventions. Aim of the study was to investigate the distribution of endocrine stimulation tests and the prevalence of pathological findings over a year and to explore whether single basal hormone concentrations could have saved unnecessary stimulation tests.
Retrospective study with data collection for pediatric endocrine stimulation tests performed in 2019 in a tertiary center.
Overall, 278 tests were performed on 206 patients. The most performed test was arginine tolerance test (34%), followed by LHRH test (24%) and standard dose Synachthen test (19%), while the higher rate of pathological response was found in insulin tolerance test to detect growth hormone deficiency (81%), LHRH test to detect central precocious puberty (50%) and arginine tolerance test (41%). No cases of non-classical-congenital adrenal hyperplasia were diagnosed. While 29% of growth hormone deficient children who performed an insulin tolerance test had a pathological peak cortisol, none of them had central adrenal insufficiency confirmed at low dose Synacthen test. The use of basal hormone determinations could save up to 88% of standard dose Synachthen tests, 82% of arginine tolerance + GHRH test, 61% of LHRH test, 12% of tests for adrenal secretion.
The use of single basal hormone concentrations could spare up to half of the tests, saving from 32,000 to 79,000 euros in 1 year. Apart from basal cortisol level <108 nmol/L to detect adrenal insufficiency and IGF-1 <-1.5 SDS to detect growth hormone deficiency, all the other cut-off for basal hormone determinations were found valid in order to spare unnecessary stimulation tests.
儿科内分泌学在很大程度上依赖于激素刺激试验,而这些试验需要时间、金钱和精力。因此,了解儿科内分泌学刺激试验的模式对于优化资源和指导公共卫生干预至关重要。本研究的目的是调查一年内内分泌刺激试验的分布情况和病理结果的患病率,并探讨单一基础激素浓度是否可以避免不必要的刺激试验。
进行回顾性研究,收集2019年在一家三级中心进行的儿科内分泌刺激试验的数据。
总体而言,对206名患者进行了278次试验。进行最多的试验是精氨酸耐量试验(34%),其次是促黄体生成素释放激素(LHRH)试验(24%)和标准剂量的促肾上腺皮质激素(Synachthen)试验(19%),而在检测生长激素缺乏的胰岛素耐量试验中病理反应率较高(81%),在检测中枢性性早熟的LHRH试验中(50%)以及精氨酸耐量试验中(41%)。未诊断出非经典型先天性肾上腺皮质增生症病例。虽然进行胰岛素耐量试验的生长激素缺乏儿童中有29%的人皮质醇峰值病理异常,但在低剂量促肾上腺皮质激素试验中均未确诊为中枢性肾上腺功能不全。使用基础激素测定可节省高达88%的标准剂量促肾上腺皮质激素试验、82%的精氨酸耐量+生长激素释放激素(GHRH)试验、61%的LHRH试验、12%的肾上腺分泌试验。
使用单一基础激素浓度可节省多达一半的试验,一年内可节省32,000至79,000欧元。除了基础皮质醇水平<108 nmol/L用于检测肾上腺功能不全和胰岛素样生长因子-1(IGF-1)<-1.5标准差评分(SDS)用于检测生长激素缺乏外,发现所有其他基础激素测定的临界值对于避免不必要的刺激试验都是有效的。